The existing literature is somewhat conflicting with respect to the role of statins in controlling levels of IL-6, two recent meta-analyses discrediting any role of statins for improvement of the IL-6 concentration in either cardiovascular or renal disease patients [53,54]. The gene discussed is IL6; the disease is kidney disorder.